As part of the European study TRANS-EURO, at the beginning of 2015-16, five patients with Parkinson's disease will be submitted to transplants of neurons in the HSkåne University Hospital of Lund, Sweden.
These are the first operations of this type in Europe for more than 10 years.
After many years will be carried out again transplants of neurons, which gives hope to many patients who suffer from Parkinson's disease. Credit: Depositphotos.
The Transeuropean study, which in Sweden is being led by the University of Lund, is now taking a critical approach to the viability of the cell therapy as a future treatment for Parkinson's disease.
Can we replace the cells that die as a result of our neurological diseases more common? What are the therapies of the future for neurodegenerative diseases such as Parkinson's and Alzheimer's disease?
Under the direction of professor of neurology Olle Lindwall, researchers from the University of Lund had already developed a method of transplantation of nerve cells in the 1980s.
In 1987, the neurosurgeon Stig Rehncrona operated the first patient. This study was historic, and marked the first repair of the human nervous system.
"From the progress made in the 1980s and 1990s, the field of research has been found with many obstacles.
At the beginning of the decade of 2000, two American studies reported a negative result, which led to the cell transplants for Parkinson's disease to a blind alley", said professor Anders Björklund, who in the 1980s was responsible for the innovative discoveries.
Despite the unsatisfactory results presented at the us trials, has even been considered that the cell therapy can have effects that are completely unique in the history of research on Parkinson's disease.
A third of patients who have received transplants, have benefited significantly from the cell therapy, and have not had to take medication for very long periods of time, in some cases up to 20 years.
"For a disease with a regimen of medication administered very demanding, and for which, the effects of the standard medication begin to decrease after 5 to 10 years, the cell therapy represents a hope for a different kind of life for many patients with Parkinson's disease," said Professor Håkan Widner, which is responsible for the recruitment of patients in Lund.
"The results of TRANS-EURO will play an important role in the immediate future of the cell therapy as a viable treatment.
We have analyzed the American studios that failed in an attempt to improve the technique, in order to improve the selection of patients and perform more custom tracking.
We hope that the results will be different this time," concluded professor Widner.
Fuente: Lunds Universitet
. via: http://cienciaaldia.com/
Leer entrada en EspañolEspañol
*English is not my mother tongue if you find errors in the translation please comment to correct them.
No comments:
Post a Comment